Zobrazeno 1 - 10
of 16
pro vyhledávání: ''
Publikováno v:
Clinical Lung Cancer. 22:e646-e653
Background Non-small cell lung cancer (NSCLC) is responsible for the most cancer-related deaths in the United States. A better understanding of treatment-related disparities and ways to address them are important to improving survival for patients wi
Autor:
Stefan Janssen, Andrea Wittig, Guido Hildebrandt, Eleni Gkika, Fabian Lohaus, E. Schrade, Detlef Imhoff, Lorenz Uhlmann, Peter Hass, Christoph Henkenberens, Denise Bernhardt, Hans-Ulrich Herold, Irina Sackerer, Oliver Blanck, Davide Scafa, Juliane Hörner-Rieber, Arndt-Christian Mueller, Robert Krempien, H. Kahl, Hans Th. Eich, Matthias Guckenberger, Marciana Nona Duma, Stefan Friedrich Lautenschläger, Sabine Gerum, Katrin Jurianz, Cordula Petersen
Publikováno v:
Clinical Lung Cancer. 20:e667-e677
This multicenter study aims to analyze outcome as well as early versus late patterns of recurrence following pulmonary stereotactic body radiotherapy (SBRT) for patients with oligometastatic non-small-cell lung cancer (NSCLC).This analysis included 3
Autor:
Yujun Zhang, Ping Hu, Ping Gu, Changhui Li, Fang Hu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Bo Zhang, Huimin Wang, Xueyan Zhang, Wei Nie
Publikováno v:
Clinical Lung Cancer. 20:e81-e90
Background For oligometastatic lung adenocarcinoma patients with sensitive epidermal growth factor receptor (EGFR) mutations, the role of local consolidative therapy (LCT) remains debatable. The purpose of this study was to investigate the efficacy o
Autor:
Wen Yu, Xiaolong Fu, Chen-Chen Zhang, Bo Zhang, Tian-Le Shen, Xueru Zhu, Xiaoyang Li, Hong-yan Zhang
Publikováno v:
Clinical lung cancer. 21(6)
Background Reliable prediction of progression patterns and failure sites for patients with stage IV lung adenocarcinoma is valuable for physicians to deliver personalized tyrosine kinase inhibitor (TKI) treatment. Patients and Methods We retrospectiv
Autor:
Eiji Shimizu, Takashi Sumikawa, Hiroyuki Maeta, Yasuto Ueda, Hiroki Izumi, Akira Yamasaki, Shu Nakamoto
Publikováno v:
Clinical Lung Cancer. 19:e63-e66
Autor:
Philip J. Stephens, Vincent A. Miller, Sai-Hong Ignatius Ou, Jeffrey S. Ross, Siraj M. Ali, Justin M. Allen, Rachel L. Erlich, Alexa B. Schrock, Davood Vafai
Publikováno v:
Clinical Lung Cancer. 18:e219-e222
Autor:
Peter G. Maxim, Michael F. Gensheimer, Rachel Liang, Frederick M. Lartey, Everett J. Moding, Arthur Sung, Billy W. Loo, Maximilian Diehn
Publikováno v:
Clinical lung cancer. 20(6)
Introduction Stereotactic ablative radiotherapy (SABR) is highly effective at controlling early stage primary lung cancer and lung metastases. Although previous studies have suggested that treating multiple lung tumors with SABR is safe, post-treatme
Autor:
Cristina Teixidó, Noemi Reguart, Pedro Jares, Clara Mayo-de-las-Casas, Miguel Angel Molina-Vila, Ivan Vollmer, Mónica Garzón, Elba Marin, Carlos Cabrera, Roxana Reyes
Publikováno v:
Clinical lung cancer. 20(3)
Autor:
Enrico Cortesi, Giuseppe Minniti, Mattia Falchetto Osti, Vitaliana De Sanctis, Alessia Carnevale, Maurizio Valeriani, Massimo Martelli, Riccardo Maurizi Enrici
Publikováno v:
Clinical Lung Cancer. 14:699-703
Introduction Stereotactic body radiation therapy is an emerging noninvasive technique for the treatment of oligometastatic cancer. The use of small numbers of large doses achieve a high percentage of local control. The aim of this study was to evalua
Autor:
Michael Koutsilieris, Konstantinos Syrigos, Haralampos Maragos, Anastasia Katseli, Adrianos Nezos
Publikováno v:
Clinical Lung Cancer. 14:513-520
Introduction The aim of this study was to develop a multiplex polymerase chain reaction (PCR)-based method for detection of circulating tumor cells in peripheral blood of lung cancer (LC) patients. Patients and Methods Peripheral blood was collected